Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ipilimumab/Pembrolizumab

Adrenocorticotropic hormone deficiency and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
Country of occurrence, reporter country and primary source country not stated. Author's communication details not available.
 
Literatur
Zurück zum Zitat AO'Hare J, et al. Isolated ACTH Deficiency after Treatment with Immune- Checkpoint Inhibitors. Journal of the Endocrine Society 13 (Suppl.): Apr 2019. Available from: URL: https://dx.doi.org/10.1210/js.2019-MON-361 [abstract] AO'Hare J, et al. Isolated ACTH Deficiency after Treatment with Immune- Checkpoint Inhibitors. Journal of the Endocrine Society 13 (Suppl.): Apr 2019. Available from: URL: https://​dx.​doi.​org/​10.​1210/​js.​2019-MON-361 [abstract]
Metadaten
Titel
Ipilimumab/Pembrolizumab
Adrenocorticotropic hormone deficiency and lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56889-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Prednisolone

Case report

Leuprorelin

Case report

Obinutuzumab

Case report

Multiple drugs